Navigation Links
Researchers map all the fragile sites of the yeast Saccharomyces cerevisiae's genome
Date:2/9/2010

Montral, February 8, 2010- The research group of Dr. Franois Robert, a researcher at the Institut de recherches cliniques de Montral (IRCM), in collaboration with the team of Dr. Daniel Durocher (Samuel Lunenfeld Research Institute and University of Toronto) accomplished a technical breakthrough: they mapped all the fragile sites of a living organism, the budding yeast Saccharomyces cerevisiae. The method used by the researchers can be applied to humans. This study has been published online today in the scientific journal Nature Structural and Molecular Biology.

S. cerevisiae is a model organism commonly used in molecular biology to study basic cellular phenomena such as the regulation of gene expression, DNA replication or, as in the present case, DNA repair. DNA, which forms the genetic material of our cells, is continuously under stress challenging its integrity. On average, the DNA contained in each one of our cells suffers, on a daily basis, about 1 million damages. If not repaired, those genetic damages can lead to cancers. Hopefully, each cell has mechanisms that detect and then repair these injuries. It has long been known that some areas of the genome were more susceptible to be damaged than others. However, a complete list of those fragile areas had not been drafted until now.

The researchers made an unexpected discovery as they analyzed the newly identified fragile sites. They found that many of those fragile sites were located in regions of the genome that contained inactive genes. "This observation was quite surprising, commented Dr. Robert, because previous studies suggested, on the contrary, that the most active genes were more at risk." Pushing their investigation further, the scientists found that the way in which inactive genes were "wrapped" was what made them most fragile. "Inactive genes are wrapped more tightly than active genes, and our results suggest that this wrapping makes them more vulnerable. This comes as a surprise. Intuitively, one would have thought that this tight wrapping would have provided a greater protection."

DNA damages tend to occur at these fragile sites and they play a key role in cancers. Since the methods that were used for this study can easily be adapted to human cells, this key phenomenon in cancer development could be better understood.

"The research that Drs. Durocher and Robert and their teams have undertaken improves our ability to identify changes in DNA, and increases our understanding of how these changes influence the likelihood of developing cancer," said Dr. Morag Park, Scientific Director of the Institute of Cancer Research, part of the Canadian Institutes of Health Research (CIHR), the Government of Canada's health research agency. "CIHR is proud to support the work of Canadian researchers who are illuminating the mechanisms that lead to formation of cancerous cells, which can lead to preventative therapies as well as more effective treatments for those already afflicted with cancer."

Dr. Robert's work was supported by the Institute of Cancer Research (ICR) of the Canadian Institutes of Health Research (CIHR). Dr. Durocher received financial support from the Canadian Cancer Society.

References for this article are available at: http://www.nature.com/nsmb/journal/vaop/ncurrent/index.html

Dr. Franois Robert is Assistant Research Professor IRCM and Director of the Chromatin and Genomic Expression Research Unit at the IRCM. He is also Assistant Research Professor in the Department of Medicine at Universit de Montral, and Adjunct Professor in the Department of Biology at the Universit de Sherbrooke. He is a recipient of the Maud Menten New Principal Investigator PrizeBiomedical Theme awarded by the Canadian Institutes of Health Research (CIHR) Institute of Genetics (IG).

Established in 1967, the IRCM (www.ircm.qc.ca) now has 36 research units specialized in areas as diverse as immunity and viral infections, cardiovascular and metabolic diseases, cancer, neurobiology and development, systems biology and medicinal chemistry, clinical research and bioethics. It has a staff of more than 450 people. The IRCM is an independent institution, affiliated with the Universit de Montral and its clinic is associated to the Centre hospitalier de l'Universit de Montral (CHUM). The IRCM holds a close collaboration with McGill University.


'/>"/>

Contact: Dr. Franois Robert
Francois.Robert@ircm.qc.ca
514-987-5737
Institut de recherches cliniques de Montreal
Source:Eurekalert

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
4. Bipolar disorder relapses halved by Melbourne researchers
5. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
6. High and mighty: first common height gene identified by researchers behind obesity gene finding
7. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
8. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
9. Researchers develop long-lasting growth hormone
10. Jefferson immunology researchers halt lethal rabies infection in brain
11. Purdue researchers develop technology to detect cancer by scanning surface veins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... , ... As health professionals work to improve their approach to healthcare, there ... more than filling out a survey; in many cases health professionals and patients are ... care and research on the importance of active engagement with patients and members of ...
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected Warren ... James C. Puffer upon his retirement. Dr. Newton will serve in the position of ... end of 2018. Upon assuming the role of President and CEO on January 1, ...
(Date:10/13/2017)... Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD ... dose required and providing a CBD form that can be easily incorporated into liquid ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Lori R. ... a member of ElderCounsel, a national organization of elder law and special needs planning ... laws and rules. It also provides a forum to network with elder law attorneys ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that ... insurance companies have a waiver for care if the client has a cognitive impairment ... family pays for care, is often waived, so the benefits from their insurance start ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)...  BioPharmX Corporation (NYSE MKT: BPMX) researchers were part ... way to use nonlinear optical imaging to confirm the ... A presentation ... how researchers from BioPharmX and the Wellman Center for ... suite of imaging techniques in what is called "Pharmacokinetic ...
(Date:10/11/2017)... -- Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today provided an ... Puerto Rico , where the company ... Following a comprehensive onsite assessment, ... damage, temporary loss of power and minimal water damage ... operations have resumed, and the company expects to return ...
(Date:10/7/2017)... Texas , Oct. 6, 2017   Provista, ... with more than $100 billion in purchasing power, today ... news and information. The Newsroom is the ... and industry trends, infographics, expert bios, news releases, slideshows ... having access to a wealth of resources at their ...
Breaking Medicine Technology: